STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-10-14

AUTHORS

Ji-Sun Lee, Ju-Hee Kang, Hye-Jin Boo, Su-Jung Hwang, Sungyoul Hong, Su-Chan Lee, Young-Jun Park, Tae-Moon Chung, Hyewon Youn, Seung Mi Lee, Byoung Jae Kim, June-Key Chung, Yeonseok Chung, William N. William, Young Kee Shin, Hyo-Jong Lee, Seung-Hyun Oh, Ho-Young Lee

ABSTRACT

Drug resistance is a major impediment in medical oncology. Recent studies have emphasized the importance of the tumour microenvironment (TME) to innate resistance, to molecularly targeted therapies. In this study, we investigate the role of TME in resistance to cixutumumab, an anti-IGF-1R monoclonal antibody that has shown limited clinical efficacy. We show that treatment with cixutumumab accelerates tumour infiltration of stromal cells and metastatic tumour growth, and decreases overall survival of mice. Cixutumumab treatment stimulates STAT3-dependent transcriptional upregulation of IGF-2 in cancer cells and recruitment of macrophages and fibroblasts via paracrine IGF-2/IGF-2R activation, resulting in the stroma-derived CXCL8 production, and thus angiogenic and metastatic environment. Silencing IGF-2 or STAT3 expression in cancer cells or IGF-2R or CXCL8 expression in stromal cells significantly inhibits the cancer–stroma communication and vascular endothelial cells’ angiogenic activities. These findings suggest that blocking the STAT3/IGF-2/IGF-2R intercellular signalling loop may overcome the adverse consequences of anti-IGF-1R monoclonal antibody-based therapies. More... »

PAGES

8499

References to SciGraph publications

  • 2005-01-01. Focal adhesion kinase: in command and control of cell motility in NATURE REVIEWS MOLECULAR CELL BIOLOGY
  • 2011-03-07. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression in NATURE MEDICINE
  • 2012-03-14. Clinical development of insulin-like growth factor receptor—1 (IGF-1R) inhibitors: At the crossroad? in INVESTIGATIONAL NEW DRUGS
  • 2012-10-22. Mesenchymal stem cells promote growth and angiogenesis of tumors in mice in ONCOGENE
  • 2013-08-13. Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines in JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
  • 2009-03-05. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits in NATURE REVIEWS CANCER
  • 2003-10-20. Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death in ONCOGENE
  • 2012-08-05. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B in NATURE MEDICINE
  • 2001-05-03. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells in ONCOGENE
  • 2006-03-30. Fibroblasts in cancer in NATURE REVIEWS CANCER
  • 2011-08-29. Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties in ONCOGENE
  • 2013-08-04. An interleukin-17–mediated paracrine network promotes tumor resistance to anti-angiogenic therapy in NATURE MEDICINE
  • 2010-06-07. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer in ONCOGENE
  • 2008-02-05. Interactions between microenvironment and cancer cells in two animal models of bone metastasis in BRITISH JOURNAL OF CANCER
  • 2011-11-07. Tumor angiogenesis: molecular pathways and therapeutic targets in NATURE MEDICINE
  • 2011-01-31. Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling in ONCOGENE
  • 2012-07-04. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors in NATURE
  • 2011-06-08. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis in NATURE
  • 2013-04-19. A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2011-11-19. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression in CANCER AND METASTASIS REVIEWS
  • 2007-06. Heterotrimeric G Proteins and the Single-Transmembrane Domain IGF-II/M6P Receptor: Functional Interaction and Relevance to Cell Signaling in MOLECULAR NEUROBIOLOGY
  • 2008-03-12. Microenvironmental regulation of metastasis in NATURE REVIEWS CANCER
  • 2008-11-28. Early development of human hematopoietic and acquired immune systems in new born NOD/Scid/Jak3null mice intrahepatic engrafted with cord blood-derived CD34+ cells in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2012-07-04. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion in NATURE
  • 2009-08-20. Environment-mediated drug resistance: a major contributor to minimal residual disease in NATURE REVIEWS CANCER
  • Journal

    TITLE

    Nature Communications

    ISSUE

    1

    VOLUME

    6

    Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/ncomms9499

    DOI

    http://dx.doi.org/10.1038/ncomms9499

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1008301521

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/26465273


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Monoclonal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Monoclonal, Humanized", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cellular Reprogramming", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Resistance, Neoplasm", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Human Umbilical Vein Endothelial Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Insulin-Like Growth Factor II", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Interleukin-8", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice, Inbred BALB C", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice, Inbred NOD", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice, Nude", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice, SCID", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasm Invasiveness", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasms, Experimental", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neovascularization, Pathologic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Paracrine Communication", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptor, IGF Type 1", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptor, IGF Type 2", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "STAT3 Transcription Factor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tumor Microenvironment", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151 742, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151 742, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lee", 
            "givenName": "Ji-Sun", 
            "id": "sg:person.01224225311.90", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224225311.90"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "National Cancer Center, Goyang-si, Gyeonggi-do 410 769, Korea", 
              "id": "http://www.grid.ac/institutes/grid.410914.9", 
              "name": [
                "National Cancer Center, Goyang-si, Gyeonggi-do 410 769, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kang", 
            "givenName": "Ju-Hee", 
            "id": "sg:person.01050765112.11", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050765112.11"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151 742, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151 742, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Boo", 
            "givenName": "Hye-Jin", 
            "id": "sg:person.0717333566.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717333566.35"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "College of Pharmacy, Inje University, Gimhae, Gyeongnam 621 749, Korea", 
              "id": "http://www.grid.ac/institutes/grid.411612.1", 
              "name": [
                "College of Pharmacy, Inje University, Gimhae, Gyeongnam 621 749, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hwang", 
            "givenName": "Su-Jung", 
            "id": "sg:person.0712072240.90", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712072240.90"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151 742, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151 742, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hong", 
            "givenName": "Sungyoul", 
            "id": "sg:person.016272044457.26", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016272044457.26"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151 742, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151 742, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lee", 
            "givenName": "Su-Chan", 
            "id": "sg:person.0733614115.20", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733614115.20"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151 742, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151 742, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Park", 
            "givenName": "Young-Jun", 
            "id": "sg:person.01074247566.96", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074247566.96"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Nuclear Medicine, Cancer Imaging Center, Seoul National University Hospital, 110 744, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.412484.f", 
              "name": [
                "Department of Nuclear Medicine, Cancer Imaging Center, Seoul National University Hospital, 110 744, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chung", 
            "givenName": "Tae-Moon", 
            "id": "sg:person.0677244362.97", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677244362.97"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Nuclear Medicine, Cancer Imaging Center, Seoul National University Hospital, 110 744, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.412484.f", 
              "name": [
                "Department of Nuclear Medicine, Cancer Imaging Center, Seoul National University Hospital, 110 744, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Youn", 
            "givenName": "Hyewon", 
            "id": "sg:person.01226613531.96", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226613531.96"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Obstetrics and Gynecology, Seoul National University College of Medicine, 110 744, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "Department of Obstetrics and Gynecology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, 156 707, Seoul, Korea", 
                "Department of Obstetrics and Gynecology, Seoul National University College of Medicine, 110 744, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mi Lee", 
            "givenName": "Seung", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Obstetrics and Gynecology, Seoul National University College of Medicine, 110 744, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "Department of Obstetrics and Gynecology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, 156 707, Seoul, Korea", 
                "Department of Obstetrics and Gynecology, Seoul National University College of Medicine, 110 744, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jae Kim", 
            "givenName": "Byoung", 
            "id": "sg:person.01170574121.77", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170574121.77"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Nuclear Medicine, Cancer Imaging Center, Seoul National University Hospital, 110 744, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.412484.f", 
              "name": [
                "Department of Nuclear Medicine, Cancer Imaging Center, Seoul National University Hospital, 110 744, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chung", 
            "givenName": "June-Key", 
            "id": "sg:person.0751347234.39", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151 742, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151 742, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chung", 
            "givenName": "Yeonseok", 
            "id": "sg:person.01343511510.91", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01343511510.91"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, 77030, Houston, Texas, USA", 
              "id": "http://www.grid.ac/institutes/grid.240145.6", 
              "name": [
                "Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, 77030, Houston, Texas, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "William", 
            "givenName": "William N.", 
            "id": "sg:person.01262777171.70", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262777171.70"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "The Center for Anti-Cancer CDx, N-Bio, Seoul National University, 151 742, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151 742, Korea", 
                "The Center for Anti-Cancer CDx, N-Bio, Seoul National University, 151 742, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kee Shin", 
            "givenName": "Young", 
            "id": "sg:person.0627531621.47", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627531621.47"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "College of Pharmacy, Inje University, Gimhae, Gyeongnam 621 749, Korea", 
              "id": "http://www.grid.ac/institutes/grid.411612.1", 
              "name": [
                "College of Pharmacy, Inje University, Gimhae, Gyeongnam 621 749, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lee", 
            "givenName": "Hyo-Jong", 
            "id": "sg:person.01362436632.43", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362436632.43"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "College of Pharmacy, Gachon University, 406 840, Inchon, Korea", 
              "id": "http://www.grid.ac/institutes/grid.256155.0", 
              "name": [
                "College of Pharmacy, Gachon University, 406 840, Inchon, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Oh", 
            "givenName": "Seung-Hyun", 
            "id": "sg:person.010640736367.59", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010640736367.59"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151 742, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151 742, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lee", 
            "givenName": "Ho-Young", 
            "id": "sg:person.011537516560.15", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011537516560.15"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/sj.onc.1204349", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003489702", 
              "https://doi.org/10.1038/sj.onc.1204349"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1756-9966-32-51", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030668475", 
              "https://doi.org/10.1186/1756-9966-32-51"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/onc.2010.640", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007760714", 
              "https://doi.org/10.1038/onc.2010.640"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/onc.2011.378", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050610628", 
              "https://doi.org/10.1038/onc.2011.378"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrm1549", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014928904", 
              "https://doi.org/10.1038/nrm1549"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm.2890", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017506378", 
              "https://doi.org/10.1038/nm.2890"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm.2537", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031152422", 
              "https://doi.org/10.1038/nm.2537"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12185-008-0215-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023141594", 
              "https://doi.org/10.1007/s12185-008-0215-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/onc.2010.215", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020707098", 
              "https://doi.org/10.1038/onc.2010.215"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10637-012-9811-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030263541", 
              "https://doi.org/10.1007/s10637-012-9811-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10549-013-2528-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037031036", 
              "https://doi.org/10.1007/s10549-013-2528-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/onc.2012.458", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040933920", 
              "https://doi.org/10.1038/onc.2012.458"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1206943", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014233561", 
              "https://doi.org/10.1038/sj.onc.1206943"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrc2620", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000031106", 
              "https://doi.org/10.1038/nrc2620"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm.2328", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049114986", 
              "https://doi.org/10.1038/nm.2328"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature11183", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053677952", 
              "https://doi.org/10.1038/nature11183"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10555-011-9340-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052919379", 
              "https://doi.org/10.1007/s10555-011-9340-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature11249", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006053948", 
              "https://doi.org/10.1038/nature11249"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6604238", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018861713", 
              "https://doi.org/10.1038/sj.bjc.6604238"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrc2714", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020069608", 
              "https://doi.org/10.1038/nrc2714"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrc1877", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036672274", 
              "https://doi.org/10.1038/nrc1877"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrc2618", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049326401", 
              "https://doi.org/10.1038/nrc2618"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature10138", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006413353", 
              "https://doi.org/10.1038/nature10138"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12035-007-0021-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034254616", 
              "https://doi.org/10.1007/s12035-007-0021-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm.3291", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043481588", 
              "https://doi.org/10.1038/nm.3291"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2015-10-14", 
        "datePublishedReg": "2015-10-14", 
        "description": "Drug resistance is a major impediment in medical oncology. Recent studies have emphasized the importance of the tumour microenvironment (TME) to innate resistance, to molecularly targeted therapies. In this study, we investigate the role of TME in resistance to cixutumumab, an anti-IGF-1R monoclonal antibody that has shown limited clinical efficacy. We show that treatment with cixutumumab accelerates tumour infiltration of stromal cells and metastatic tumour growth, and decreases overall survival of mice. Cixutumumab treatment stimulates STAT3-dependent transcriptional upregulation of IGF-2 in cancer cells and recruitment of macrophages and fibroblasts via paracrine IGF-2/IGF-2R activation, resulting in the stroma-derived CXCL8 production, and thus angiogenic and metastatic environment. Silencing IGF-2 or STAT3 expression in cancer cells or IGF-2R or CXCL8 expression in stromal cells significantly inhibits the cancer\u2013stroma communication and vascular endothelial cells\u2019 angiogenic activities. These findings suggest that blocking the STAT3/IGF-2/IGF-2R intercellular signalling loop may overcome the adverse consequences of anti-IGF-1R monoclonal antibody-based therapies.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/ncomms9499", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2438826", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2476720", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1043282", 
            "issn": [
              "2041-1723"
            ], 
            "name": "Nature Communications", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "6"
          }
        ], 
        "keywords": [
          "tumor microenvironment", 
          "IGF-2R", 
          "IGF-2", 
          "stromal cells", 
          "role of TME", 
          "cancer-stroma communication", 
          "IGF-2 secretion", 
          "cancer cells", 
          "monoclonal antibody-based therapies", 
          "limited clinical efficacy", 
          "antibody-based therapies", 
          "metastatic tumor growth", 
          "recruitment of macrophages", 
          "vascular endothelial cells", 
          "Cixutumumab treatment", 
          "overall survival", 
          "medical oncology", 
          "clinical efficacy", 
          "CXCL8 production", 
          "tumor infiltration", 
          "CXCL8 expression", 
          "metastatic environment", 
          "tumor growth", 
          "drug resistance", 
          "monoclonal antibodies", 
          "endothelial cells", 
          "angiogenic activity", 
          "STAT3 expression", 
          "therapy", 
          "adverse consequences", 
          "transcriptional upregulation", 
          "antibodies", 
          "Recent studies", 
          "cells", 
          "treatment", 
          "cixutumumab", 
          "IGF", 
          "expression", 
          "mice", 
          "oncology", 
          "macrophages", 
          "secretion", 
          "upregulation", 
          "efficacy", 
          "survival", 
          "infiltration", 
          "STAT3", 
          "resistance", 
          "elicits", 
          "study", 
          "microenvironment", 
          "activation", 
          "major impediment", 
          "fibroblasts", 
          "findings", 
          "recruitment", 
          "activity", 
          "role", 
          "consequences", 
          "importance", 
          "production", 
          "growth", 
          "impediments", 
          "loop", 
          "communication", 
          "environment"
        ], 
        "name": "STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody", 
        "pagination": "8499", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1008301521"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/ncomms9499"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "26465273"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/ncomms9499", 
          "https://app.dimensions.ai/details/publication/pub.1008301521"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-12-01T06:33", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_673.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/ncomms9499"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/ncomms9499'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/ncomms9499'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/ncomms9499'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/ncomms9499'


     

    This table displays all metadata directly associated to this object as RDF triples.

    460 TRIPLES      21 PREDICATES      139 URIs      106 LITERALS      30 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/ncomms9499 schema:about N17e3655778c540f7901d10c0435986fc
    2 N1c2ac50f3936445398288136484c9d27
    3 N243b938791df4d74a40d7a5939182923
    4 N47c6f85765624386aa6050996356ecd4
    5 N51a292ece33c4fdcb0e9f5ebb61f575d
    6 N55f5dac792264e0ca3c52e53bb35e43e
    7 N68a8b16eba594556ab3690b6b2ce3654
    8 N705d08ec45914a66971339e67fb7a686
    9 N706c3c7c96fd484f8e5f844e8f66ab46
    10 N8a85137592374309b3cf772adadc0029
    11 Na91aae19cf194ed5bc909fe0468e2789
    12 Nc1a964f1872f49d3ae2aed59b956c8a1
    13 Nc37d12342e284c03b41e5e2e1983f18b
    14 Nc646feb65d3449978343429e13fff849
    15 Nc9593754d1124981bc8e062cecebc110
    16 Ncf42269f7a704982934a1903a14a1829
    17 Nd769229f2f444a9498756da28c2a352d
    18 Ndab0a49ba94642e7b8a0949789369c51
    19 Ndca1473d3cc447fe9ffe54c11846c205
    20 Ne8329646824943488e75a69c55ef44c5
    21 Neac8ebe346744761b771ce0cc6cc52f3
    22 Nebe32c07eb5f4fb1b2b6839b02c1a84d
    23 Nefecb20cb72f4fe5a793342b6cc36aaa
    24 anzsrc-for:11
    25 anzsrc-for:1112
    26 schema:author N0c1f1ffd721c4b8aad4e9f3b97fe579c
    27 schema:citation sg:pub.10.1007/s10549-013-2528-8
    28 sg:pub.10.1007/s10555-011-9340-x
    29 sg:pub.10.1007/s10637-012-9811-0
    30 sg:pub.10.1007/s12035-007-0021-2
    31 sg:pub.10.1007/s12185-008-0215-z
    32 sg:pub.10.1038/nature10138
    33 sg:pub.10.1038/nature11183
    34 sg:pub.10.1038/nature11249
    35 sg:pub.10.1038/nm.2328
    36 sg:pub.10.1038/nm.2537
    37 sg:pub.10.1038/nm.2890
    38 sg:pub.10.1038/nm.3291
    39 sg:pub.10.1038/nrc1877
    40 sg:pub.10.1038/nrc2618
    41 sg:pub.10.1038/nrc2620
    42 sg:pub.10.1038/nrc2714
    43 sg:pub.10.1038/nrm1549
    44 sg:pub.10.1038/onc.2010.215
    45 sg:pub.10.1038/onc.2010.640
    46 sg:pub.10.1038/onc.2011.378
    47 sg:pub.10.1038/onc.2012.458
    48 sg:pub.10.1038/sj.bjc.6604238
    49 sg:pub.10.1038/sj.onc.1204349
    50 sg:pub.10.1038/sj.onc.1206943
    51 sg:pub.10.1186/1756-9966-32-51
    52 schema:datePublished 2015-10-14
    53 schema:datePublishedReg 2015-10-14
    54 schema:description Drug resistance is a major impediment in medical oncology. Recent studies have emphasized the importance of the tumour microenvironment (TME) to innate resistance, to molecularly targeted therapies. In this study, we investigate the role of TME in resistance to cixutumumab, an anti-IGF-1R monoclonal antibody that has shown limited clinical efficacy. We show that treatment with cixutumumab accelerates tumour infiltration of stromal cells and metastatic tumour growth, and decreases overall survival of mice. Cixutumumab treatment stimulates STAT3-dependent transcriptional upregulation of IGF-2 in cancer cells and recruitment of macrophages and fibroblasts via paracrine IGF-2/IGF-2R activation, resulting in the stroma-derived CXCL8 production, and thus angiogenic and metastatic environment. Silencing IGF-2 or STAT3 expression in cancer cells or IGF-2R or CXCL8 expression in stromal cells significantly inhibits the cancer–stroma communication and vascular endothelial cells’ angiogenic activities. These findings suggest that blocking the STAT3/IGF-2/IGF-2R intercellular signalling loop may overcome the adverse consequences of anti-IGF-1R monoclonal antibody-based therapies.
    55 schema:genre article
    56 schema:isAccessibleForFree true
    57 schema:isPartOf N9ba844604c2f4abf92178d7248eb3916
    58 Nbac073215d8e4c878b1bb091727f5acc
    59 sg:journal.1043282
    60 schema:keywords CXCL8 expression
    61 CXCL8 production
    62 Cixutumumab treatment
    63 IGF
    64 IGF-2
    65 IGF-2 secretion
    66 IGF-2R
    67 Recent studies
    68 STAT3
    69 STAT3 expression
    70 activation
    71 activity
    72 adverse consequences
    73 angiogenic activity
    74 antibodies
    75 antibody-based therapies
    76 cancer cells
    77 cancer-stroma communication
    78 cells
    79 cixutumumab
    80 clinical efficacy
    81 communication
    82 consequences
    83 drug resistance
    84 efficacy
    85 elicits
    86 endothelial cells
    87 environment
    88 expression
    89 fibroblasts
    90 findings
    91 growth
    92 impediments
    93 importance
    94 infiltration
    95 limited clinical efficacy
    96 loop
    97 macrophages
    98 major impediment
    99 medical oncology
    100 metastatic environment
    101 metastatic tumor growth
    102 mice
    103 microenvironment
    104 monoclonal antibodies
    105 monoclonal antibody-based therapies
    106 oncology
    107 overall survival
    108 production
    109 recruitment
    110 recruitment of macrophages
    111 resistance
    112 role
    113 role of TME
    114 secretion
    115 stromal cells
    116 study
    117 survival
    118 therapy
    119 transcriptional upregulation
    120 treatment
    121 tumor growth
    122 tumor infiltration
    123 tumor microenvironment
    124 upregulation
    125 vascular endothelial cells
    126 schema:name STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody
    127 schema:pagination 8499
    128 schema:productId N1b3dbdbf11cb4ced83302d3eb0175aa4
    129 N85693c83b7534fac8fd08683f26a1d84
    130 Nf6e0cebeef4244d29902003e9cca8eee
    131 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008301521
    132 https://doi.org/10.1038/ncomms9499
    133 schema:sdDatePublished 2022-12-01T06:33
    134 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    135 schema:sdPublisher Nbb35368a4f2c4cf8a0a8125ce02ea2e4
    136 schema:url https://doi.org/10.1038/ncomms9499
    137 sgo:license sg:explorer/license/
    138 sgo:sdDataset articles
    139 rdf:type schema:ScholarlyArticle
    140 N0446c1e4501d4a638b9e13edf4b6fe42 schema:affiliation grid-institutes:grid.31501.36
    141 schema:familyName Mi Lee
    142 schema:givenName Seung
    143 rdf:type schema:Person
    144 N0c1f1ffd721c4b8aad4e9f3b97fe579c rdf:first sg:person.01224225311.90
    145 rdf:rest N9c56c99b28764effb8e7a7aa7779dc3e
    146 N16b1ea0b72ea4e919a9fff116e97c6ca rdf:first sg:person.01226613531.96
    147 rdf:rest N8da89cc01a7b4372870ab3409426ba02
    148 N17e3655778c540f7901d10c0435986fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    149 schema:name Neovascularization, Pathologic
    150 rdf:type schema:DefinedTerm
    151 N1b3dbdbf11cb4ced83302d3eb0175aa4 schema:name doi
    152 schema:value 10.1038/ncomms9499
    153 rdf:type schema:PropertyValue
    154 N1c2ac50f3936445398288136484c9d27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    155 schema:name Mice, Inbred NOD
    156 rdf:type schema:DefinedTerm
    157 N2415a29c67214b53898b0c954b9f508b rdf:first sg:person.0677244362.97
    158 rdf:rest N16b1ea0b72ea4e919a9fff116e97c6ca
    159 N243b938791df4d74a40d7a5939182923 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Neoplasm Invasiveness
    161 rdf:type schema:DefinedTerm
    162 N2e5a04d4148945658712d93ac1721ce1 rdf:first sg:person.0712072240.90
    163 rdf:rest Nef6ccd751fd84d04acc35812626c5982
    164 N47c6f85765624386aa6050996356ecd4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name Animals
    166 rdf:type schema:DefinedTerm
    167 N51a292ece33c4fdcb0e9f5ebb61f575d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    168 schema:name Receptor, IGF Type 1
    169 rdf:type schema:DefinedTerm
    170 N55f5dac792264e0ca3c52e53bb35e43e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    171 schema:name Cell Line, Tumor
    172 rdf:type schema:DefinedTerm
    173 N5b479060debf427a9937f9d2f0cc1d56 rdf:first sg:person.01262777171.70
    174 rdf:rest N70a1cd8e3c194757b038e1507b2f3cc5
    175 N65e4ce09b6b649ffa8a634090fe669c3 rdf:first sg:person.01170574121.77
    176 rdf:rest N9b7804813bfb4453b0b2f65902d7d3f6
    177 N68a8b16eba594556ab3690b6b2ce3654 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    178 schema:name Drug Resistance, Neoplasm
    179 rdf:type schema:DefinedTerm
    180 N705d08ec45914a66971339e67fb7a686 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    181 schema:name Interleukin-8
    182 rdf:type schema:DefinedTerm
    183 N706c3c7c96fd484f8e5f844e8f66ab46 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    184 schema:name Mice, SCID
    185 rdf:type schema:DefinedTerm
    186 N70a1cd8e3c194757b038e1507b2f3cc5 rdf:first sg:person.0627531621.47
    187 rdf:rest Nf8c00e5e96be4c7bb3ffff8a1fe5c323
    188 N74236fbbb90f413f854ca2f98a66c6e4 rdf:first sg:person.0733614115.20
    189 rdf:rest N9ecf2e992ecd4764bcc2175418b22930
    190 N85693c83b7534fac8fd08683f26a1d84 schema:name dimensions_id
    191 schema:value pub.1008301521
    192 rdf:type schema:PropertyValue
    193 N8a85137592374309b3cf772adadc0029 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    194 schema:name Mice
    195 rdf:type schema:DefinedTerm
    196 N8da89cc01a7b4372870ab3409426ba02 rdf:first N0446c1e4501d4a638b9e13edf4b6fe42
    197 rdf:rest N65e4ce09b6b649ffa8a634090fe669c3
    198 N92a973633db0477e938c4ea9f5891a5f rdf:first sg:person.010640736367.59
    199 rdf:rest Ne941456afadc4550a8f5144db9741550
    200 N9b7804813bfb4453b0b2f65902d7d3f6 rdf:first sg:person.0751347234.39
    201 rdf:rest Na68975debebd44079f8e4a882cf54955
    202 N9ba844604c2f4abf92178d7248eb3916 schema:issueNumber 1
    203 rdf:type schema:PublicationIssue
    204 N9c56c99b28764effb8e7a7aa7779dc3e rdf:first sg:person.01050765112.11
    205 rdf:rest N9e309e993fd54f40a69e6be4fc4c19ef
    206 N9e309e993fd54f40a69e6be4fc4c19ef rdf:first sg:person.0717333566.35
    207 rdf:rest N2e5a04d4148945658712d93ac1721ce1
    208 N9ecf2e992ecd4764bcc2175418b22930 rdf:first sg:person.01074247566.96
    209 rdf:rest N2415a29c67214b53898b0c954b9f508b
    210 Na68975debebd44079f8e4a882cf54955 rdf:first sg:person.01343511510.91
    211 rdf:rest N5b479060debf427a9937f9d2f0cc1d56
    212 Na91aae19cf194ed5bc909fe0468e2789 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    213 schema:name Antibodies, Monoclonal, Humanized
    214 rdf:type schema:DefinedTerm
    215 Nbac073215d8e4c878b1bb091727f5acc schema:volumeNumber 6
    216 rdf:type schema:PublicationVolume
    217 Nbb35368a4f2c4cf8a0a8125ce02ea2e4 schema:name Springer Nature - SN SciGraph project
    218 rdf:type schema:Organization
    219 Nc1a964f1872f49d3ae2aed59b956c8a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    220 schema:name Mice, Nude
    221 rdf:type schema:DefinedTerm
    222 Nc37d12342e284c03b41e5e2e1983f18b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    223 schema:name Humans
    224 rdf:type schema:DefinedTerm
    225 Nc646feb65d3449978343429e13fff849 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    226 schema:name Receptor, IGF Type 2
    227 rdf:type schema:DefinedTerm
    228 Nc9593754d1124981bc8e062cecebc110 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    229 schema:name Insulin-Like Growth Factor II
    230 rdf:type schema:DefinedTerm
    231 Ncf42269f7a704982934a1903a14a1829 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    232 schema:name Tumor Microenvironment
    233 rdf:type schema:DefinedTerm
    234 Nd769229f2f444a9498756da28c2a352d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    235 schema:name STAT3 Transcription Factor
    236 rdf:type schema:DefinedTerm
    237 Ndab0a49ba94642e7b8a0949789369c51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    238 schema:name Cellular Reprogramming
    239 rdf:type schema:DefinedTerm
    240 Ndca1473d3cc447fe9ffe54c11846c205 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    241 schema:name Paracrine Communication
    242 rdf:type schema:DefinedTerm
    243 Ne8329646824943488e75a69c55ef44c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    244 schema:name Human Umbilical Vein Endothelial Cells
    245 rdf:type schema:DefinedTerm
    246 Ne941456afadc4550a8f5144db9741550 rdf:first sg:person.011537516560.15
    247 rdf:rest rdf:nil
    248 Neac8ebe346744761b771ce0cc6cc52f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    249 schema:name Mice, Inbred BALB C
    250 rdf:type schema:DefinedTerm
    251 Nebe32c07eb5f4fb1b2b6839b02c1a84d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    252 schema:name Neoplasms, Experimental
    253 rdf:type schema:DefinedTerm
    254 Nef6ccd751fd84d04acc35812626c5982 rdf:first sg:person.016272044457.26
    255 rdf:rest N74236fbbb90f413f854ca2f98a66c6e4
    256 Nefecb20cb72f4fe5a793342b6cc36aaa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    257 schema:name Antibodies, Monoclonal
    258 rdf:type schema:DefinedTerm
    259 Nf6e0cebeef4244d29902003e9cca8eee schema:name pubmed_id
    260 schema:value 26465273
    261 rdf:type schema:PropertyValue
    262 Nf8c00e5e96be4c7bb3ffff8a1fe5c323 rdf:first sg:person.01362436632.43
    263 rdf:rest N92a973633db0477e938c4ea9f5891a5f
    264 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    265 schema:name Medical and Health Sciences
    266 rdf:type schema:DefinedTerm
    267 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    268 schema:name Oncology and Carcinogenesis
    269 rdf:type schema:DefinedTerm
    270 sg:grant.2438826 http://pending.schema.org/fundedItem sg:pub.10.1038/ncomms9499
    271 rdf:type schema:MonetaryGrant
    272 sg:grant.2476720 http://pending.schema.org/fundedItem sg:pub.10.1038/ncomms9499
    273 rdf:type schema:MonetaryGrant
    274 sg:journal.1043282 schema:issn 2041-1723
    275 schema:name Nature Communications
    276 schema:publisher Springer Nature
    277 rdf:type schema:Periodical
    278 sg:person.01050765112.11 schema:affiliation grid-institutes:grid.410914.9
    279 schema:familyName Kang
    280 schema:givenName Ju-Hee
    281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050765112.11
    282 rdf:type schema:Person
    283 sg:person.010640736367.59 schema:affiliation grid-institutes:grid.256155.0
    284 schema:familyName Oh
    285 schema:givenName Seung-Hyun
    286 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010640736367.59
    287 rdf:type schema:Person
    288 sg:person.01074247566.96 schema:affiliation grid-institutes:grid.31501.36
    289 schema:familyName Park
    290 schema:givenName Young-Jun
    291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074247566.96
    292 rdf:type schema:Person
    293 sg:person.011537516560.15 schema:affiliation grid-institutes:grid.31501.36
    294 schema:familyName Lee
    295 schema:givenName Ho-Young
    296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011537516560.15
    297 rdf:type schema:Person
    298 sg:person.01170574121.77 schema:affiliation grid-institutes:grid.31501.36
    299 schema:familyName Jae Kim
    300 schema:givenName Byoung
    301 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170574121.77
    302 rdf:type schema:Person
    303 sg:person.01224225311.90 schema:affiliation grid-institutes:grid.31501.36
    304 schema:familyName Lee
    305 schema:givenName Ji-Sun
    306 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224225311.90
    307 rdf:type schema:Person
    308 sg:person.01226613531.96 schema:affiliation grid-institutes:grid.412484.f
    309 schema:familyName Youn
    310 schema:givenName Hyewon
    311 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226613531.96
    312 rdf:type schema:Person
    313 sg:person.01262777171.70 schema:affiliation grid-institutes:grid.240145.6
    314 schema:familyName William
    315 schema:givenName William N.
    316 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262777171.70
    317 rdf:type schema:Person
    318 sg:person.01343511510.91 schema:affiliation grid-institutes:grid.31501.36
    319 schema:familyName Chung
    320 schema:givenName Yeonseok
    321 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01343511510.91
    322 rdf:type schema:Person
    323 sg:person.01362436632.43 schema:affiliation grid-institutes:grid.411612.1
    324 schema:familyName Lee
    325 schema:givenName Hyo-Jong
    326 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362436632.43
    327 rdf:type schema:Person
    328 sg:person.016272044457.26 schema:affiliation grid-institutes:grid.31501.36
    329 schema:familyName Hong
    330 schema:givenName Sungyoul
    331 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016272044457.26
    332 rdf:type schema:Person
    333 sg:person.0627531621.47 schema:affiliation grid-institutes:grid.31501.36
    334 schema:familyName Kee Shin
    335 schema:givenName Young
    336 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627531621.47
    337 rdf:type schema:Person
    338 sg:person.0677244362.97 schema:affiliation grid-institutes:grid.412484.f
    339 schema:familyName Chung
    340 schema:givenName Tae-Moon
    341 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677244362.97
    342 rdf:type schema:Person
    343 sg:person.0712072240.90 schema:affiliation grid-institutes:grid.411612.1
    344 schema:familyName Hwang
    345 schema:givenName Su-Jung
    346 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712072240.90
    347 rdf:type schema:Person
    348 sg:person.0717333566.35 schema:affiliation grid-institutes:grid.31501.36
    349 schema:familyName Boo
    350 schema:givenName Hye-Jin
    351 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717333566.35
    352 rdf:type schema:Person
    353 sg:person.0733614115.20 schema:affiliation grid-institutes:grid.31501.36
    354 schema:familyName Lee
    355 schema:givenName Su-Chan
    356 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733614115.20
    357 rdf:type schema:Person
    358 sg:person.0751347234.39 schema:affiliation grid-institutes:grid.412484.f
    359 schema:familyName Chung
    360 schema:givenName June-Key
    361 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39
    362 rdf:type schema:Person
    363 sg:pub.10.1007/s10549-013-2528-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037031036
    364 https://doi.org/10.1007/s10549-013-2528-8
    365 rdf:type schema:CreativeWork
    366 sg:pub.10.1007/s10555-011-9340-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1052919379
    367 https://doi.org/10.1007/s10555-011-9340-x
    368 rdf:type schema:CreativeWork
    369 sg:pub.10.1007/s10637-012-9811-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030263541
    370 https://doi.org/10.1007/s10637-012-9811-0
    371 rdf:type schema:CreativeWork
    372 sg:pub.10.1007/s12035-007-0021-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034254616
    373 https://doi.org/10.1007/s12035-007-0021-2
    374 rdf:type schema:CreativeWork
    375 sg:pub.10.1007/s12185-008-0215-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1023141594
    376 https://doi.org/10.1007/s12185-008-0215-z
    377 rdf:type schema:CreativeWork
    378 sg:pub.10.1038/nature10138 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006413353
    379 https://doi.org/10.1038/nature10138
    380 rdf:type schema:CreativeWork
    381 sg:pub.10.1038/nature11183 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053677952
    382 https://doi.org/10.1038/nature11183
    383 rdf:type schema:CreativeWork
    384 sg:pub.10.1038/nature11249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006053948
    385 https://doi.org/10.1038/nature11249
    386 rdf:type schema:CreativeWork
    387 sg:pub.10.1038/nm.2328 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049114986
    388 https://doi.org/10.1038/nm.2328
    389 rdf:type schema:CreativeWork
    390 sg:pub.10.1038/nm.2537 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031152422
    391 https://doi.org/10.1038/nm.2537
    392 rdf:type schema:CreativeWork
    393 sg:pub.10.1038/nm.2890 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017506378
    394 https://doi.org/10.1038/nm.2890
    395 rdf:type schema:CreativeWork
    396 sg:pub.10.1038/nm.3291 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043481588
    397 https://doi.org/10.1038/nm.3291
    398 rdf:type schema:CreativeWork
    399 sg:pub.10.1038/nrc1877 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036672274
    400 https://doi.org/10.1038/nrc1877
    401 rdf:type schema:CreativeWork
    402 sg:pub.10.1038/nrc2618 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049326401
    403 https://doi.org/10.1038/nrc2618
    404 rdf:type schema:CreativeWork
    405 sg:pub.10.1038/nrc2620 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000031106
    406 https://doi.org/10.1038/nrc2620
    407 rdf:type schema:CreativeWork
    408 sg:pub.10.1038/nrc2714 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020069608
    409 https://doi.org/10.1038/nrc2714
    410 rdf:type schema:CreativeWork
    411 sg:pub.10.1038/nrm1549 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014928904
    412 https://doi.org/10.1038/nrm1549
    413 rdf:type schema:CreativeWork
    414 sg:pub.10.1038/onc.2010.215 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020707098
    415 https://doi.org/10.1038/onc.2010.215
    416 rdf:type schema:CreativeWork
    417 sg:pub.10.1038/onc.2010.640 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007760714
    418 https://doi.org/10.1038/onc.2010.640
    419 rdf:type schema:CreativeWork
    420 sg:pub.10.1038/onc.2011.378 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050610628
    421 https://doi.org/10.1038/onc.2011.378
    422 rdf:type schema:CreativeWork
    423 sg:pub.10.1038/onc.2012.458 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040933920
    424 https://doi.org/10.1038/onc.2012.458
    425 rdf:type schema:CreativeWork
    426 sg:pub.10.1038/sj.bjc.6604238 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018861713
    427 https://doi.org/10.1038/sj.bjc.6604238
    428 rdf:type schema:CreativeWork
    429 sg:pub.10.1038/sj.onc.1204349 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003489702
    430 https://doi.org/10.1038/sj.onc.1204349
    431 rdf:type schema:CreativeWork
    432 sg:pub.10.1038/sj.onc.1206943 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014233561
    433 https://doi.org/10.1038/sj.onc.1206943
    434 rdf:type schema:CreativeWork
    435 sg:pub.10.1186/1756-9966-32-51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030668475
    436 https://doi.org/10.1186/1756-9966-32-51
    437 rdf:type schema:CreativeWork
    438 grid-institutes:grid.240145.6 schema:alternateName Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, 77030, Houston, Texas, USA
    439 schema:name Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, 77030, Houston, Texas, USA
    440 rdf:type schema:Organization
    441 grid-institutes:grid.256155.0 schema:alternateName College of Pharmacy, Gachon University, 406 840, Inchon, Korea
    442 schema:name College of Pharmacy, Gachon University, 406 840, Inchon, Korea
    443 rdf:type schema:Organization
    444 grid-institutes:grid.31501.36 schema:alternateName College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151 742, Korea
    445 Department of Obstetrics and Gynecology, Seoul National University College of Medicine, 110 744, Seoul, Korea
    446 The Center for Anti-Cancer CDx, N-Bio, Seoul National University, 151 742, Seoul, Korea
    447 schema:name College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151 742, Korea
    448 Department of Obstetrics and Gynecology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, 156 707, Seoul, Korea
    449 Department of Obstetrics and Gynecology, Seoul National University College of Medicine, 110 744, Seoul, Korea
    450 The Center for Anti-Cancer CDx, N-Bio, Seoul National University, 151 742, Seoul, Korea
    451 rdf:type schema:Organization
    452 grid-institutes:grid.410914.9 schema:alternateName National Cancer Center, Goyang-si, Gyeonggi-do 410 769, Korea
    453 schema:name National Cancer Center, Goyang-si, Gyeonggi-do 410 769, Korea
    454 rdf:type schema:Organization
    455 grid-institutes:grid.411612.1 schema:alternateName College of Pharmacy, Inje University, Gimhae, Gyeongnam 621 749, Korea
    456 schema:name College of Pharmacy, Inje University, Gimhae, Gyeongnam 621 749, Korea
    457 rdf:type schema:Organization
    458 grid-institutes:grid.412484.f schema:alternateName Department of Nuclear Medicine, Cancer Imaging Center, Seoul National University Hospital, 110 744, Seoul, Korea
    459 schema:name Department of Nuclear Medicine, Cancer Imaging Center, Seoul National University Hospital, 110 744, Seoul, Korea
    460 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...